G. Chiritescu

Phase I study of Aplidine in a daily×5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115

J. Maroun, K. Bélanger, Lesley Seymour et al. · Annals of Oncology · 2006 · 70 citations

Medicine, Oncology, Pharmacology +6

Skin toxicities of targeted therapies

Siegfried Segaert, G. Chiritescu, Liesbeth Lemmens et al. · European Journal of Cancer · 2009 · 64 citations

Medicine, Dermatology, Pharmacology +13

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial

M. Verstraete, Annelies Debucquoy, Jeroen Dekervel et al. · British Journal of Cancer · 2015 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17